Literature DB >> 8627768

Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

J M Jacqué1, B Fernández, F Arenzana-Seisdedos, D Thomas, F Baleux, J L Virelizier, F Bachelerie.   

Abstract

This work aimed to ascertain the role of kappaB-responsive elements of the human immunodeficiency virus type 1 (HIV-1) enhancer not only in early initiation but also in long-term maintenance of proviral transcription in cells of the monocytic lineage. For this purpose, we used three main approaches. The first was to abruptly terminate tumor necrosis factor-induced NF-kappaB binding to the enhancer sequences in U1 monocytic cells, using a short pulse of exogenous tumor necrosis factor. This resulted in concomitant decrease in nuclear NF-kappaB DNA-binding activity and endogenous long terminal repeat transcriptional activity. The second was to suppress the permanent NF-kappaB translocation induced by HIV-1 replication itself in chronically infected U937 cells, using a specific proteasome inhibitor (Z-LLL-H). As early as 2 h after addition of the inhibitor to the culture medium, there was an inhibition of both constitutive activation of NF-kappaB and HIV-1 genome expression. The third approach was to monitor the replication competence in U937 cells of an infectious HIV-1 provirus carrying point mutations in the kappaB-responsive elements of both long terminal repeats. Compared with its wild-type counterpart, this mutated provirus showed a profoundly decreased, Z-LLL-H-insensitive transcriptional and replicative activity in U937 monocytes. Together, our results indicate that occupancy of the viral enhancer by NF-kappaB (p50/p65) heterodimers is required for ongoing transcription of integrated HIV provirus in monocytes, even in cells chronically infected and permanently producing functional HIV Tat protein. Thus, the ability of HIV-1 replication to activate NF-kappaB is crucial to the intense self-perpetuated viral transcription observed in cells of the monocytic lineage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627768      PMCID: PMC190151     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Method for cloning single-stranded oligonucleotides in a plasmid vector.

Authors:  P Mounts; T C Wu; K Peden
Journal:  Biotechniques       Date:  1989-04       Impact factor: 1.993

3.  Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.

Authors:  S J Arrigo; S Weitsman; J D Rosenblatt; I S Chen
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

5.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

6.  Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.

Authors:  G Poli; A Kinter; J S Justement; J H Kehrl; P Bressler; S Stanley; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

7.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

Review 8.  Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.

Authors:  A Roulston; R Lin; P Beauparlant; M A Wainberg; J Hiscott
Journal:  Microbiol Rev       Date:  1995-09

9.  I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B.

Authors:  J E Thompson; R J Phillips; H Erdjument-Bromage; P Tempst; S Ghosh
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

10.  Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.

Authors:  G E Griffin; K Leung; T M Folks; S Kunkel; G J Nabel
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

View more
  15 in total

1.  Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.

Authors:  Ann Florence B Victoriano; Kaori Asamitsu; Yurina Hibi; Kenichi Imai; Nina G Barzaga; Takashi Okamoto
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Proline-proline-glutamic acid (PPE) protein Rv1168c of Mycobacterium tuberculosis augments transcription from HIV-1 long terminal repeat promoter.

Authors:  Khalid Hussain Bhat; Chinta Krishna Chaitanya; Nazia Parveen; Raja Varman; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

3.  NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages.

Authors:  S Asin; G D Bren; E M Carmona; N J Solan; C V Paya
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Reciprocal modulatory interaction between human immunodeficiency virus type 1 Tat and transcription factor NFAT1.

Authors:  F Macián; A Rao
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  Diazepam-mediated inhibition of human immunodeficiency virus type 1 expression in human brain cells.

Authors:  J R Lokensgard; G Gekker; S Hu; A F Arthur; C C Chao; P K Peterson
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Endothelial cells enhance human immunodeficiency virus type 1 replication in macrophages through a C/EBP-dependent mechanism.

Authors:  E S Lee; H Zhou; A J Henderson
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Anti-CD45RO suppresses human immunodeficiency virus type 1 replication in microglia: role of Hck tyrosine kinase and implications for AIDS dementia.

Authors:  Mee-Ohk Kim; Hyeon-Sook Suh; Qiusheng Si; Bruce I Terman; Sunhee C Lee
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation.

Authors:  C DeLuca; A Roulston; A Koromilas; M A Wainberg; J Hiscott
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

9.  Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells.

Authors:  Mingce Zhang; Adrian Clausell; Tanya Robinson; Jiyi Yin; Eric Chen; Leanne Johnson; Greta Weiss; Steffanie Sabbaj; Robert M Lowe; Fred H Wagner; Paul A Goepfert; Olaf Kutsch; Randy Q Cron
Journal:  J Immunol       Date:  2012-08-08       Impact factor: 5.422

Review 10.  Benzodiazepines, glia, and HIV-1 neuropathogenesis.

Authors:  J R Lokensgard; C C Chao; G Gekker; S Hu; P K Peterson
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.